Subjects will be expected to attend 3 scheduled visits.
The purpose of this clinical trial is to assess the clinical performance of LID# 223194 Multifocal (MF) contact lens and a commercially available Air Optix plus HydraGlyde (AOHG) MF contact lens. Eligible subjects will wear each study lens type in a cross-over fashion as randomized for approximately 2 days.